https://ecommons.aku.edu/crm/19/
"Bortezomib (velcade) induces p27Kip1 expression through S-phase kinase" by Shahab Uddin, Maqbool...
S-phase kinase protein 2 (SKP2), an F-box protein, targets cell cycle regulators including cycle-dependent kinase inhibitor p27Kip1 via ubiquitin-mediated...
velcadeinducesexpressionphasekinase
https://www.nationdrugs.to/drugs/Velcade
NationDrugs | Velcade
velcade
https://www.cancernetwork.com/view/velcadedoxil-approved-relapsed-or-refractory-multiple-myeloma-pts
Velcade/Doxil Approved for Relapsed or Refractory Multiple Myeloma Pts | CancerNetwork
May 11, 2026 - The US Food and Drug Administration (FDA) has approved the use of Doxil (doxorubicin liposome injection, Ortho Biotech) in combination with Velcade for...
multiple myelomavelcadeapprovedrefractorypts
https://peoplebeatingcancer.org/velcade-builds-bone-and-kills-myeloma/
Velcade Builds Bone and kills Myeloma - PeopleBeatingCancer
Sep 22, 2024 - Velcade builds bone and kills myeloma at the same time. Because 90% of MM patients struggle with "skeletal related events" (SRE)
velcadebuildsbonekillsmyeloma
https://pharsight.greyb.com/drug/velcade-patent-expiration
Velcade patent expiration
Find out all the patents protecting Velcade drug, its owner, and when it is going to expire, along with insights into its generic launch
velcadepatentexpiration